[Inflammatory response in pneumonia: are glucocorticosteroids useful?].
Agustí
C
C
Torres
A
A
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001426:Bacterial Proteins; D002352:Carrier Proteins / Q000378:metabolism; D016207:Cytokines / Q000276:immunology*; D006602:Hexosyltransferases; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D007378:Interleukins / Q000276:immunology; D002267:Muramoylpentapeptide Carboxypeptidase / Q000378:metabolism; D046915:Penicillin-Binding Proteins; D010458:Peptidyl Transferases; D011014:Pneumonia / Q000188:drug therapy* / Q000276:immunology*; D011486:Protein C / Q000096:biosynthesis; D013256:Steroids; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D001426:Bacterial Proteins; D002352:Carrier Proteins; D016207:Cytokines; D007378:Interleukins; D046915:Penicillin-Binding Proteins; D011486:Protein C; D013256:Steroids; D014409:Tumor Necrosis Factor-alpha; D015378:Imipenem; D010458:Peptidyl Transferases; D006602:Hexosyltransferases; D002267:Muramoylpentapeptide Carboxypeptidase
Respuesta inflamatoria en la neumonía: ¿son útiles los glucocorticoides?